High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs
Nucleic Acids Research · 2025
DOI: 10.1093/nar/gkaf730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Aruun Beharry und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, The University of Western Ontario, London, Ontario, N6A 5C1, Canada. Hauptthemen laut MEDLINE: Codon, Nonsense, Frontotemporal Dementia, RNA, Transfer, Arg, RNA, Transfer. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHGRI NIH HHS, Huntington Society of Canada Research Chair, CIHR.
Themen: Demenz
Abstract (Originalsprache)
Nonsense mutations generate premature termination codons (PTCs) that are responsible for 11% of genetic disease alleles. The arginine (Arg, CGA) to stop (UGA) mutation is the most common PTC. Humans encode >600 transfer RNA (tRNA) genes with many identical and similar copies. We developed a dual fluorescent reporter to quantify PTC readthrough in live cells and found single nucleotide mutations of human tRNAArg gene variants enabled differential nonsense suppression that depended on the tRNA sequence and the cell type. We investigated G36A variants of all six human tRNAArgUCG isodecoders, and only the TCG-6-1 tRNA, where G36A occurs in 0.01% of human genomes, was unable to translate nonsense codons. With tRNA sequencing, we showed that a suppressor tRNA derived from the TCG-3-1 gene was expressed 2.1-fold higher and generated 1.8-fold more nonsense suppression than a tRNA derived from the TCG-4-1 gene. In a neuroblastoma model of frontotemporal dementia, we observed >70% readthrough of progranulin R493X with a suppressor tRNA that represented 5%–18% of the total tRNAArg pool. The tRNAs outperformed aminoglycoside-induced nonsense suppression in efficacy, tolerability to the cells, and translation fidelity according to mass spectrometry. Our studies show that human nonsense suppressor tRNAs can correct genetic defects that cause disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, The University of Western Ontario, London, Ontario, N6A 5C1, Canada.
- Department of Biomolecular Engineering, Baskin School of Engineering & UCSC Genomics Institute, University of California Santa Cruz, Santa Cruz, CA 95064, United States.
- Bioinformatics Solutions, Inc., Waterloo, Ontario, N2L 3K8, Canada.
- Department of Chemistry, The University of Western Ontario, London, Ontario, N6A 5C1, Canada.
ORCID-Profile: Patricia P Chan, Todd M Lowe, Patrick O'Donoghue
Förderung
- NHGRI NIH HHS
- Huntington Society of Canada Research Chair
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Canada Research Chairs
- Canadian Institutes of Health Research
Zitieren
APA
Beharry, A., Ward, C., Moore, H., Hoffman, K. S., Chan, P. P., Lowe, T. M., & O'Donoghue, P. (2025). High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf730
Vancouver
Beharry A, Ward C, Moore H, Hoffman KS, Chan PP, Lowe TM, et al. High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf730
BibTeX
@article{Beharry2025,
author = {Beharry, Aruun and Ward, Cian and Moore, Henry and Hoffman, Kyle S and Chan, Patricia P and Lowe, Todd M and O'Donoghue, Patrick},
title = {High-fidelity and differential nonsense suppression in live cells and a frontotemporal dementia allele with human transfer RNAs},
journal = {Nucleic Acids Research},
year = {2025},
doi = {10.1093/nar/gkaf730}
}
EUVIMED